With all eyes locked on this morning's CPI release and the Strait of Hormuz nearly shut down, Wall Street analysts are already repositioning across hospitality, pharma, and tech before the market even opens.
Empowered Funds LLC lifted its position in shares of IDEX Corporation (NYSE: IEX) by 95.7% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,418 shares of the industrial products company's stock after buying an additional 4,116 shares during the quarter. Empowered
Amundi trimmed its holdings in IDEX Corporation (NYSE: IEX) by 18.0% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,219,400 shares of the industrial products company's stock after selling 268,259 shares during the quarter. Amundi owned about
IDEX Corporation (NYSE: IEX - Get Free Report)'s stock price reached a new 52-week high during trading on Wednesday following a better than expected earnings announcement. The stock traded as high as $232.55 and last traded at $239.8090, with a volume of 608 shares. The stock had previously closed at $224.65. The industrial products company reported
IDEX NYSE: IEX reported second-quarter 2026 results that exceeded its expectations, supported by growth in its Health & Science Technologies segment, stronger orders and operational execution. The company raised its full-year outlook for organic sales growth, adjusted EBITDA margin and adjusted earnings per share.
The headline numbers for Idex (IEX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.